MCL1 and neoplasm: One study demonstrated that deletion or pharmacologic inhibition of MCL-1-induced DNA damage and cell-cycle arrest regardless of an intact apoptotic pathway [73], suggesting that non-apoptotic functions of the BCL-2 family antagonism also contribute to the overall tumor-suppressing effects of the BH3-mimetics.